SCHEMBL4692140

SCHEMBL4692140

O=C(O)c1ccc2c(c1)N(c1cc(Cl)cc(Cl)c1)C(=O)C2Cc1ccc(Br)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGAL P20701 9/20 0.38
ITGB2 P05107 8/20 0.38
ICAM1 P05362 8/20 0.38
CES2 O00748 1/20 0.36
CXCR3 P49682 1/20 0.35
HPGD P15428 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
HDAC6 Q9UBN7 2/20 0.35
HDAC3 O15379 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC9 Q9UKV0 1/20 0.35
HDAC5 Q9UQL6 1/20 0.35
MRGPRX4 Q96LA9 2/20 0.34
RXRA P19793 1/20 0.34
RXRB P28702 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4689907 0.84 ITGAL (0.36) ITGALITGB2ICAM1CES2ALOX5
SCHEMBL4692248 0.81 ALOX5 (0.47) ITGALITGB2ICAM1CES2ALOX5
SCHEMBL4690047 0.76 ITGAL (0.40) ITGALITGB2ICAM1CES2ALOX5
SCHEMBL4687837 0.75 ITGAL (0.40) ITGALITGB2ICAM1CES2ALOX5
SCHEMBL4687956 0.74 ALOX5 (0.50) ITGALITGB2ICAM1CES2ALOX5
SCHEMBL4693030 0.70 GAA (0.39) ITGALITGB2ICAM1CES2ALOX5
SCHEMBL4687618 0.68 ITGB2 (0.41) ITGALITGB2ICAM1CES2ALOX5
SCHEMBL22898546 0.66 RAB9A (0.58) ITGALITGB2ICAM1
SCHEMBL4690051 0.65 ALOX5 (0.46) ITGALITGB2ICAM1CES2ALOX5
SCHEMBL6664550 0.64 ROCK2 (0.43) HPGDMRGPRX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1399155-B1 SMALL MOLECULES USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASE BOEHRINGER INGELHEIM PHARMA (US) 2008-05-28 EP claimed
US-6414153-B1 TREATMENT OF INFLAMMATORY OR IMMUNE CELL-MEDIATED DISEASE OR CONDITION BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2002-07-02 US claimed
EP-1399155-B1 SMALL MOLECULES USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASE BOEHRINGER INGELHEIM PHARMA (US) 2008-05-28 EP disclosed
US-6414153-B1 TREATMENT OF INFLAMMATORY OR IMMUNE CELL-MEDIATED DISEASE OR CONDITION BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2002-07-02 US disclosed